[Form 4] Atlassian Corporation Insider Trading Activity
Rhea-AI Filing Summary
Michael Cannon-Brookes, Atlassian Corp (TEAM) CEO and 10% owner, reported multiple sales of Class A common stock on 08/19/2025 executed under a Rule 10b5-1 trading plan adopted on 02/20/2025. The filings show five separate dispositions totaling 7,665 shares at weighted-average prices ranging from $166.0904 to $169.83 per share, with per-lot execution ranges disclosed in footnotes. After these transactions, beneficial ownership is reported indirectly at 224,635, 224,485, 223,135, 222,635, and 222,285 shares across the reported lines, held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust. The Form 4 was signed by an attorney-in-fact on 08/20/2025.
Positive
- Transactions executed under a Rule 10b5-1 trading plan, adopted 02/20/2025, indicating pre-planned, compliant sales
- Detailed execution ranges and weighted-average prices provided in footnotes, enhancing disclosure transparency
- Beneficial ownership disclosed as held indirectly by CBC Co Pty Limited as trustee, clarifying ownership structure
Negative
- Insider sold a total of 7,665 shares on 08/19/2025, which constitutes insider liquidity
- Reported beneficial ownership decreased across the reported lines (from 224,635 down to 222,285 on different lines)
Insights
TL;DR: Routine insider dispositions under a Rule 10b5-1 plan; transaction sizes are modest relative to institutional stakes.
The report documents multiple small block sales by a principal insider executed pursuant to a pre-established 10b5-1 plan adopted on 02/20/2025. The weighted-average prices per lot are provided and range between approximately $166.09 and $169.83. The sales are recorded as indirect holdings via CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust. From a market-impact perspective, these appear to be orderly plan-driven sales rather than ad hoc dispositions.
TL;DR: Proper disclosure and use of a 10b5-1 plan reduce governance concerns but signal insider liquidity.
The filing clearly states the trades were effected pursuant to a Rule 10b5-1 plan, which provides an affirmative defense against insider trading claims when conditions are met. The presence of an attorney-in-fact signature and detailed execution price ranges in footnotes supports compliance and transparency. Nonetheless, repeated sales by a top insider warrant monitoring for any change in ownership trends.